Adverse drug reactions in a pulmonary teaching hospital: Incidence, pattern, seriousness, and preventability

Current Drug Safety

Volumn 6, Issue 4, 2011, Pages 230-236

  Baniasadi, Shadi ^a   Fahimi, Fanak ^b,c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adverse drug reaction; Clinical pharmacist; Hospital; Pharmacovigilance; Spontaneous reporting; Yellow card

Indexed keywords

ALLOPURINOL; AMIODARONE; AMOXICILLIN PLUS CLAVULANIC ACID; BETAXOLOL; CARBAMAZEPINE; CARBOPLATIN; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; CLOPIDOGREL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIGOXIN; ENOXAPARIN; GEMCITABINE; HEPARIN; ISONIAZID; ISOPHANE INSULIN; MORPHINE SULFATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIG INSULIN; PROPRANOLOL; PYRAZINAMIDE; RANITIDINE; RIFAMPICIN; SCOPOLAMINE; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VANCOMYCIN;

ABDOMINAL PAIN; ADVERSE DRUG REACTION; ALLERGIC REACTION; ANEMIA; ARTICLE; AUDITORY SYSTEM; BLOOD CLOTTING; BLURRED VISION; BRONCHOSPASM; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONSCIOUSNESS; CONVULSION; DERMATITIS; DIARRHEA; DRUG SAFETY; DYSPNEA; ECCHYMOSIS; GASTRIC ULCER BLEEDING; GASTROINTESTINAL TRACT; GENITAL SYSTEM; HEALTH EDUCATION; HEMATURIA; HEPATOBILIARY SYSTEM; HOSPITAL DEPARTMENT; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INCIDENCE; IRAN; KIDNEY DISEASE; KIDNEY FAILURE; LEUKOPENIA; LUNG EDEMA; MUSCULOSKELETAL SYSTEM; NAUSEA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; PANCYTOPENIA; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PETECHIA; PRIORITY JOURNAL; PRURITUS; RESPIRATORY SYSTEM; SIDE EFFECT; SKIN APPENDAGE; STEVENS JOHNSON SYNDROME; TEACHING HOSPITAL; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; URINARY TRACT; URTICARIA; VERTIGO; VISUAL SYSTEM; VOMITING;

EID: 83455234777     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488611798280942     Document Type: Article

References (28)

1. ASHP guidelines on adverse drug reaction monitoring and reporting. American Society of Hospital Pharmacy. Am J Health Syst Pharm 1995; 52(4): 417-9.
2. Seidl LG, Thornton GF, Cluff LE. Epidemiological studies of adverse drug reactions. Am J Public Health 1965; 55: 1170-5.
3. Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions. V-Clinical factors influencing susceptibility. Ann Intern Med 1966; 65(4): 629-40.
4. Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. BMJ 1969; 1(5643): 531-6.
5. Ogilvie RI, Ruedy J. Adverse drug reactions during hospitalisation. Can Med Assoc J 1967; 97(24): 1450-7.
6. Sullivan KM, Spooner LM. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. Am J Health Syst Pharm 2008; 65(12): 1177-9.
7. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45(3): 301-8.
8. Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006; 54(3): 226-33.
9. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol 2008; 102(4): 408-11.
10. Baniasadi S, Fahimi F. Namdar R. Development of an adverse drug reaction bulletin in a teaching hospital. Formulary 2009; 44(11): 333-35.
11. Uppsala Monitoring Centre. Adverse Reaction Terminology. World Health Organization Collaborating Centre for International Drug Monitoring, Uppsala, Sweden, 2003.
12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45.
13. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27(6): 538.
14. Pedrós C, Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009; 32(1): 77-83.
15. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200-5.
16. Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf 2007; 30(5): 379-407.
17. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 2009; 4(2): 4439.
18. Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care 2003; 15(Suppl. 1): i49-59.
19. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15-9.
20. Camargo AL, Cardoso Ferreira MB, Heineck I. Adverse drug reactions: a cohort study in internal medicine units at a University hospital. Eur J Clin Pharmacol 2006; 62(2): 143-9.
21. Schneeweiss S, Göttler M, Hasford J, et al. First results from an intensified monitoring system to estimate drug-related hospital admissions. Br J Clin Pharmacol 2001; 52(2): 196-200.
22. Suh DC, Woodall BS, Shin SK, et al. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000; 34(12): 1373-9.
23. Baniasadi S, Eftekhari P, Tabarsi P, et al. Protective effect of Nacetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol 2010; 22(10): 1235-8.
24. Fahimi F, Kobarfard F, Tabarsi P, Hemmati S, Salamzadeh J, Baniasadi S. Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center. Chemotherapy 2011; 57(1): 7-11.
25. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003; 60(17): 1750-9.
26. Murphy BM, Frigo LC. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital. Hosp Pharm 1993; 28(12): 1199-204, 1240.
27. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 1995; 274(1): 29-34.
28. Ducharme MM, Boothby LA. Analysis of adverse drug reactions for preventability. Int J Clin Pract 2007; 61(1): 157-61.